Get ready for a spine-chilling cinematic experience that’s already sparking buzz in Hollywood! Sony has emerged victorious in a fierce bidding war for Skeletons, a horror thriller that’s bringing together some of the industry’s most exciting talents. But here’s where it gets controversial: with JJ Abrams producing, Brie Larson starring, and JT Mollner directing, this project is shaping up to be a bold departure from the typical horror fare—and not everyone is convinced it’ll live up to the hype. Let’s dive into why this film is already making waves.
Sony outbid heavyweights like Paramount, Warner Bros., and Neon to secure worldwide rights to Skeletons, a project that’s been generating whispers since it hit the market. The film, co-written and directed by JT Mollner, the visionary behind Strange Darling, is based on a short story by Philip Fracassi. While Strange Darling wasn’t a box office smash, it solidified Mollner as a rising star in the genre, drawing comparisons to innovators like Zech Cregger (Weapons) and Parker Finn (Smile). But here’s the twist: Mollner’s non-linear storytelling style is a gamble—will it captivate audiences or leave them scratching their heads?
The plot of Skeletons is still shrouded in mystery, but insiders hint at a gripping tale centered on the complex relationship between a son and his mother, who is inexplicably confined to a secure cage each night. Is this a metaphor for familial bonds, a psychological thriller, or something far darker? The ambiguity is intentional, and it’s already fueling speculation. The initial script was penned by Brian Duffield, known for No One Will Save You and Love and Monsters, adding another layer of intrigue to the project.
What’s even more fascinating is the team behind the scenes. JJ Abrams, who’s been relatively quiet on the feature film front since Star Wars: The Rise of Skywalker (2019), is stepping back into the spotlight as a producer. Meanwhile, Brie Larson, fresh off her roles in The Marvels and Apple TV’s Lessons in Chemistry, is set to lead the cast. But here’s the part most people miss: Larson’s involvement in a horror thriller is a bold departure from her superhero and dramatic roles—will she nail the genre shift, or is this a risky move?
The financial stakes are high, with domestic rights reportedly landing in the mid-$20 million range and worldwide figures climbing even higher. Sony’s aggressive move to secure global rights suggests they’re betting big on Skeletons. Yet, the project’s success isn’t guaranteed. Is this the next Get Out or The Babadook, or will it fall flat like so many other high-concept horrors?
As the film gears up for production, one thing is clear: Skeletons is poised to be a conversation starter. Whether it’s Mollner’s daring direction, Larson’s genre leap, or Abrams’ return to the big screen, this thriller has all the ingredients for a cultural moment. But we want to hear from you: Are you excited for Skeletons, or do you think it’s overhyped? Let us know in the comments—this is one debate you won’t want to miss!
